Fig. 2

Subgroup analysis of patients with sclerosing cholangitis (SC). Addition of antimicrobial agents to ERC contrast media in patients with SC resulted in a significant decrease in infectious complications after ERC (9% with antibiotics vs. 50% without antibiotics, p = 0.03)